Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates.
Give to Mayo ClinicHelp set a new world standard in care for people everywhere. Give now.
Mayo Clinic offers appointments in Arizona, Florida and Minnesota and at Mayo Clinic Health System locations.
Subscribe to Housecall
Our general interest e-newsletter keeps you up to date on a wide variety of health topics.
Research continues in the development of a number of vaccines designed to prevent the recurrence of ovarian cancer. So far, ovarian cancer vaccines are available only in clinical trial studies.
One theory behind ovarian cancer vaccines is that they stimulate the immune system to detect and eliminate any cancer cells that reappear after initial treatment has been completed. Vaccines under study include abagovomab and oregovomab.
Abagovomab has been shown to elicit an immune response in women with ovarian cancer, but it's not known if this improves the outcome. Major clinical trials studying abagovomab are currently underway. Oregovomab also has been tested and has been shown to elicit an immune response. But one study showed no difference in the recurrence rate in women who got oregovomab as compared with a placebo. Other vaccines are also being studied, as are ways to help boost the effectiveness of the vaccines.
Surgery followed by chemotherapy remains the standard primary treatment for ovarian cancer. One aspect of ovarian cancer vaccine research includes examining how best to use these vaccines in combination with chemotherapy.
Although research has shown that ovarian cancer vaccines may hold promise, these studies have involved only small numbers of participants. More and larger studies are needed to further evaluate the potential role that vaccines may play in preventing recurrent ovarian cancer.
Timothy J. Moynihan, M.D.
Mayo Clinic is a not-for-profit organization. Proceeds from website advertising help support our mission. Mayo Clinic does not endorse non-Mayo products and services.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.
We comply with the HONcode standard for trustworthy health information: verify here.